Anti-tumour necrosis factor therapy for ankylosing spondylitis--unresolved issues
نویسندگان
چکیده
منابع مشابه
Anti-tumour necrosis factor α therapy for ankylosing spondylitis: international experience
The conventional approach to treatment of patients with spondyloarthritis (SpA), particularly ankylosing spondylitis (AS), has serious limitations, adding a sense of urgency to the evaluation of new treatments for these rheumatic disorders. Tumour necrosis factor α (TNFα) is a cytokine that has been shown to mediate inflammatory and regulatory activities in SpA and other immune mediated disease...
متن کاملComparison of recommendations for the use of anti-tumour necrosis factor therapy in ankylosing spondylitis in 23 countries worldwide.
OBJECTIVE To give an overview of the recommendations for the use of anti-TNF-α therapy in AS in 23 countries worldwide. METHODS The recommendations were collected, translated and a summary was checked by Assessment of SpondyloArthritis International Society (ASAS) members from the respective countries. The recommendations were compared with the ASAS recommendations (2006) on three aspects: pa...
متن کاملAnti-TNF-α Therapy for Ankylosing Spondylitis
BACKGROUND This review evaluated the safety and efficacy of etanercept in patients with ankylosing spondylitis (AS). METHODS Of 59 patients with AS, this study reviewed 11 patients who were refractory to conventional therapy and treated with etanercept from September 2005 to January 2008. The mean follow-up duration was 13.6 months. The general improvement was evaluated by the Bath Ankylosing...
متن کاملCorrection: Adverse Events of Anti-Tumor Necrosis Factor α Therapy in Ankylosing Spondylitis
In the Results section of the Abstract, there are errors in the percentages and the ratios for both the chest pain and the tuberculosis data. The correct values for chest pain are (0.2%; 1/402), and the correct values for tuberculosis are (3.5%; 6/172). Copyright: © 2015 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which per...
متن کاملPredictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis
The aim of this study was to investigate the potential predictors of switching tumor necrosis factor (TNF)-α inhibitors in Korean patients with ankylosing spondylitis (AS). The patients who had been treated with TNF-α inhibitors were divided into two groups depending on whether they had switched TNF-α inhibitors. Demographic, clinical, laboratory, and treatment data at the time of initiation of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rheumatology
سال: 2007
ISSN: 1462-0324,1462-0332
DOI: 10.1093/rheumatology/kem012